Stay updated on ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial
Sign up to get notified when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.

Latest updates to the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page
- ChecktodayChange DetectedRevision: v3.3.3 was added to the page history, while HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe history now shows an added Revision: v3.3.2 and a deleted Revision: v3.3.1 for the page.SummaryDifference0.0%

- Check29 days agoChange DetectedThe record history now shows a new Revision: v3.3.1 and removes Revision: v3.2.0. This appears to be an administrative update to the site's revision labeling.SummaryDifference0.0%

- Check36 days agoChange DetectedRemoved the banner about government funding delays and current operating status from the page header. This change affects only the UI notice and does not alter the trial data.SummaryDifference0.3%

- Check51 days agoChange DetectedA new Study Status entry was added on 2025-10-27, with version 85 documented on 2025-10-24. A prior entry from 2025-08-01 was deleted.SummaryDifference0.2%

- Check79 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference8%

Stay in the know with updates to ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.